Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Shares Outstanding (Diluted Average): 2023-2024

Historic Shares Outstanding (Diluted Average) for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to $62.5 million.

  • CG Oncology's Shares Outstanding (Diluted Average) rose 14.28% to $76.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $76.7 million, marking a year-over-year increase of 14.28%. This contributed to the annual value of $62.5 million for FY2024, which is 1343.03% up from last year.
  • According to the latest figures from FY2024, CG Oncology's Shares Outstanding (Diluted Average) is $62.5 million, which was up 1,343.03% from $4.3 million recorded in FY2023.
  • CG Oncology's Shares Outstanding (Diluted Average)'s 5-year high stood at $62.5 million during FY2024, with a 5-year trough of $4.3 million in FY2023.
  • For the 2-year period, CG Oncology's Shares Outstanding (Diluted Average) averaged around $33.4 million, with its median value being $33.4 million (2023).
  • Data for CG Oncology's Shares Outstanding (Diluted Average) shows a peak YoY surged of 1,343.03% (in 2024) over the last 5 years.
  • Over the past 2 years, CG Oncology's Shares Outstanding (Diluted Average) (Yearly) stood at $4.3 million in 2023, then spiked by 1,343.03% to $62.5 million in 2024.